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Summary Doubts have frequently been expressed about the effectiveness of the screening programme for
cervical cancer in Britain. These doubts have been reinforced as a result of recent increases in mortality from
this disease among younger women. In this paper we discuss trends in registration and mortality data, relate
these to the level of screening, and conclude that screening may in fact have had a considerable impact on
mortality rates. There is good evidence that in some age groups there has been a large increase in the
incidence of carcinoma in situ of the cervix; it seems likely that the potential increase in cervical cancer
incidence and mortality may have been partially prevented as a result of the screening programme. The extent
of this effect cannot be quantified precisely because of uncertainties concerning the natural history of cervical
cancer, differences in risk for different cohorts, and the possible effects of other factors. It is likely that
incidence rates will continue to change, and it will be necessary to monitor these and the screening
programme with some care in order to make the best use of the resources available for cervical cytology.
Yule (1978) and other authors have drawn
attention to the rising numbers of deaths from
cervical cancer among younger women during the
1970s in England and Wales. We have recently
commented on trends in both mortality and
incidence (Draper & Cook, 1982).
There have also been reports from several other
countries of an upward trend in the incidence of,
and mortality from, cancer of the cervix among
younger women. In Canada, in spite of extensive
screening programmes, there has been a recent
increase in the incidence of cancer of the cervix
among women aged 20-34 in at least two provinces
(Report of a Task Force..., 1982). Increases in the
incidence of invasive cancer of the cervix have been
reported from two Australian states: in New South
Wales the incidence of cervical cancer reported to
the Central Cancer Registry during 1972-76
increased among women aged 20-39 in the years
1975 and 1976 (Armstrong & Holman, 1981);
similarly in Queensland there was an increase in
incidence of invasive cervical cancer, excluding
microinvasive or Stage lA cancers, among women
aged 20-44 between 1974 and 1980 (Bourne &
Grove, 1983). These trends in incidence correspond
to the upward trend in mortality among younger
women in Australia reported by Armstrong and
Holman who showed that, although mortality from
cervical cancer had tended to fall progressively
since 1950, the rate for women aged less than 40
increased from about 1970. In New Zealand, Green
(1979) reported a rise in mortality among women
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aged 20-34, the rates having approximately doubled
in the period 1959-1974 in spite of the introduction
of screening. (The number of deaths in this age
group at the end of the period studied was still only
about 5 per year.)
In this paper we present a detailed analysis of
cervical cancer mortality and registration data for
England and Wales and for Scotland, examine the
rates for different cohorts and attempt to interpret
the observed trends.
Cervical cancer rates and their relationship to the
screening programme
Mortality rates
We consider mortality first because it has received
most attention in the past, is the largest continuous
series of disease rates, and is the most reliable end-
point in considering the impact of the disease on
the population. There are three possible sources of
error in the enumeration of deaths from cervical
cancer during the period considered, 1950-82. First,
alterations in disease classification and coding may
cause a spurious trend in the reported rates.
Although there have been three changes in the
International Classification of Diseases during this
period there has not been any significant alteration
in the classification or coding related to cervical
cancer. Secondly, we have assumed that there have
been no dramatic improvements in the degree of
diagnostic accuracy which might have resulted in
increased recognition of disease. Finally, a minority
of deaths from uterine cancer are classified 'site
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unspecified' as opposed to body of uterus or cervix.
This may arise either from poor recording or from
incomplete death certification or because the site of
origin of the cancer could not be truly identified. In
England and Wales the number of deaths so
classified has fluctuated between about 200 and 400
each year except in 1981 and 1982 when, as a result
of the dispute involving local Registrars and the
consequent decrease in the number of resolved
queries concerning non-specific diagnoses, there was
more than a doubling of the number of deaths
recorded as being in this category. The majority of
such deaths occur in women aged over 55 years. It
is unlikely even if these tumours could be re-
classified that they would all be attributed to
cervical cancer. We consider that the annual
fluctuations in the number of these deaths,
particularly among the younger group of women,
are too small to have influenced the observed
trends in mortality rates from cervical cancer.
Thus, for the present analysis, we feel justified in
ignoring these possible sources of error and
assuming that any trends observed do in fact reflect
true changes in mortality. It is of course also
possible that changes in mortality reflect changes in
survival rather than changes in incidence. Survival
rates for 1971 to 1975 published by OPCS (1982)
suggest that within each 10 year age group there
were only small changes in survival rates between
1971 and 1975. Data for earlier and later years
appear not to be available for individual age groups
and therefore we cannot entirely dismiss the
possibility that there have been decreases in survival
rates which could explain some of the increase in
mortality. Evidence that the changes in mortality
rates described below (Tables Ia and lb and Figure
1) are not solely due to changes in survival is
provided by data on registration rates (Tables Ila
and Ilb) which show the same general pattern.
Table Ia gives mortality rates for 3-year periods
and 10-year age groups in England and Wales for
the period 1950-82. Mortality rates for 5-year age-
groups in successive years during the same period
are shown in Figure 1. There are considerable
variations in the rates for individual age groups
during this period. At ages 25-34, and possibly 15-
24, there was a fall after the mid-1950s followed by
a steep rise starting around 1970 which has
continued until the present. At ages 35-44 the rate
rose, fell, and is now rising again. At ages 45-54
small changes during the first 20 years of the period
have been followed by a sharp decline since 1970.
The most striking recent change in mortality is the
increase at ages 25-34 where the rate has more than
doubled - though the total number of deaths in this
group is still on average only about 110 per year.
Corresponding mortality rates for Scotland are
given in Table lb. The population of Scotland and
Table Ia Deaths from cancer of the cervix in
England and Wales
Rates per million women
Age group
Year 15-24 25-34 35-44 45-54 55-64 65+
1950-52 0.6 18 74 180 300 337
1953-55 0.7 23 76 163 253 316
1956-58 0.7 24 90 163 235 318
1959-61 0.5 19 100 172 204 306
1962-64 0.5 11 103 184 193 286
1965-67 0.5 11 92 189 195 260
1968-70 1.4 11 69 189 200 247
1971-73 1.3 13 57 176 201 224
1974-76 2.1 18 46 140 208 216
1977-79 0.8 24 59 124 197 215
1980-82 2.2 30 62 100 176 203
Table lb Deaths from cancer of the cervix in
Scotland
Rates per million women
Age group
Year 15-24 25-34 35-44 45-54 55-64 65+
1950-52 0.9 18 90 149 220 185
1953-55 0.0 21 107 162 223 219
1956-58 0.9 17 107 168 220 204
1959-61 1.8 15 104 186 182 243
1962-64 0.0 12 113 207 193 210
1965-67 0.0 15 87 212 180 241
1968-70 0.0 16 67 203 217 233
1971-73 0.0 15 46 168 209 232
1974-76 0.0 14 56 135 224 211
1977-79 0.0 19 60 131 183 221
1980-82 2.3 23 58 107 175 195
the annual numbers of deaths ini each age group are
only one tenth of those in England and Wales and
there is therefore a greater degree of variation in
the death rates which makes it more difficult to
demonstrate any trends. Both the mortality rates
and the trends are similar to those for England and
Wales. Perhaps the most notable differences are the
lower rates for older age-groups in the early part of
the period and the trends for ages 45-54, where the
increase in mortality was greater for the first half of
the period and the rate then fell to a level similar to
that for England and Wales. For the age-group 25-
34 the recent rise in mortality appears to be smaller
for Scotland than for England and Wales.
Figure 1 shows in detail temporal changes in
death rates for England and Wales; it can be seenCERVICAL CANCER AND CARCINOMA IN SITU 369
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Figure 1 Age specific death rates for cervical cancer
in England and Wales 1950-1982.
that the pattern at ages 40-44 tends to follow that
for the age group 35-39 after an interval of around
5 years and similarly that the pattern of decline at
ages 45-49 is followed about 5 years later by a
corresponding decline in the age group 50-54 and
then after another interval of about five years a
decline for the age group 55-59.
These are examples of the well known
phenomenon, originally pointed out by Hill &
Adelstein (1967), that there is an important 'birth
cohort' effect in the pattern of mortality rates for
cervical cancer, that is, the rates vary according to
the year of birth of the women concerned.
Mortality data are normally published for five year
age-groups by calendar year of death; it is not
possible from such tables to determine the year of
birth of the individuals who died, but we can, for
instance, say that for deaths occurring at ages 40-44
in 1974the births occurred in years around 1931-1932.
Deaths occurring in this age-group between 1971
and 1975 relate to individuals born at times centred
on January 1st, 1931; these deaths may therefore be
classified as occurring among the '1931 (birth)
cohort'. In a similar way deaths among other age-
groups and in other years can be classified as
relating to specified cohorts, and a general picture
of mortality at successive ages for groups of
individuals born in different periods can be built
up. [See the classic paper by Case (1956), or that by
Hill & Adelstein (1967).] Hill and Adelstein showed
that if the mortality rate from cervical cancer in
one age group for women born around a particular
year is high compared with the rate for the same
age-group among those born at other times then
the rates at other ages for women born at this time
are likely to be relatively high also. This effect is
shown in Figure 2, where the mortality rates at
successive ages for England and Wales are
presented for women born in periods around 1901,
1911, etc. Women born in years around 1921 have
generally high rates, those born around 1931 have
low rates. However, the most striking feature of
Figure 2 is the increase in death rates for the
cohort of women born in the years around 1951 as
compared with those born in preceding years. A
more detailed examination of these data shows that
for each 5-year age group the mortality rates for
successive cohorts of women born around 1936,
500[
20 25 30 35 40 45 50 55 60 65 70 75
24 29 34 39 44 49 54 59 64 69 74 79
Age at death
Figure 2 Cohort mortality rates for carcinoma of the
cervix in England and Wales 1951-1980. Rates are
plotted for women dying at specified ages and born in
groups of years centred on January 1st 1901, 1911 etc.
Each point is based on mortality data for 5 years.
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1941, 1946, 1951 steadily increase. Considering the
mortality patterns for previous cohorts it would be
expected that women born around 1951 would have
high mortality rates throughout their lifespan.
Cohort effects in cervical cancer mortality rates
have been discussed by Barrett (1973) and Osmond
et al. (1982,1983). The latter have fitted equations
to the set of mortality rates for five-year age-groups
during the period 1951-1980 in order to estimate
the effects of age, birth cohort and calendar year.
This analysis shows, for instance, that the risk of
cervical cancer for women born around 1951 is
about double the risk for those born around 1941.
(In the analyses by Osmond et al. these are referred
to as the 1950 and 1940 cohorts.)
Figure 3 shows that the cohort mortality patterns
for Scotland are similar to those for England and
Wales. (The rates for the 1951 cohort, not shown in
Figure 3, were zero at ages 20-24 and 13 per
million at ages 25-29.)
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Figure 3 Cohort mortality rates for carcinoma of the
cervix in Scotland 1951-1980. Rates are plotted for
women dying at specified ages and born in groups of
years centred on January 1st 1901, 1911 etc. Each
point is based on mortality data for 5 years.
Registration ratesfor invasive cancer
Cancer registration data have been published for
the whole of England and Wales from 1962 to 1980
separately for invasive cancer of the cervix and for
carcinoma in situ. (For 1962-64 the two categories
were grouped together; however, as Parkin et al.
(1984) point out, numbers of cases of invasive
cancer and carcinoma in situ can be separated for
these years by assuming that cases classified as
premalignant uterine cancer, which are tabulated
separately, are in fact all carcinoma in situ of the
cervix and subtracting these from the grouped
cervix category to obtain the number of invasive
cases.) For reasons similar to those discussed in
relation to mortality data, trends in registration
rates have to be interpreted with some caution; we
have assumed that disease classification and
diagnostic criteria have not materially altered
during the period of observation. Nevertheless it is
well recognised that tumour registration is
incomplete and may be subject to delays. This is
unlikely to have much effect on the present
analysis: for instance revised figures for
registrations of invasive cervical cancer diagnosed
during 1966 and 1967 in England and Wales were
published in 1975, 3 years after they were originally
published - these later figures show an increase of
about 3% in the number of cases registered;
published registration data for later years have also
been revised. There may of course be late
registrations for any year but provided the
proportion of such late registrations is small and
the number unregistered is reasonably constant
from year to year this will not influence the trends.
Changes in the completeness of registration are
unlikely to produce artefactual trends which only
affect particular age groups. We believe that the
observed trends represent real increases or decreases
particularly since deaths and registrations show the
same pattern. Each year a minority of uterine
cancers are registered as 'unspecified'. This
number has trebled from 156 in 1966 to 464 in
1980. These cases occur mostly among women in
age groups above age 45 years. As with the
"unspecified" deaths, it is unlikely that all these
tumours ought to have been classified as "cervix
uteri". But even if all of them are added to the
registrations from invasive cervical cancer the
numbers are not great enough to influence the
observed trends, particularly in the younger age
groups.
For Scotland registration data are available for
the period 1959-80 separately for invasive cervical
cancer and carcinoma in situ.
In Tables Ila and lIb respectively we summarise
registration data for invasive cancer of the cervix
for England and Wales and for Scotland, giving
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Table Ila Registrations of invasive cancer of the
cervix in England and Wales
Rates per million women
Age group
Year 15-24 25-34 35-44 45-54 55-64 65+
1963-65 3 53 301 394 336 301
1966-68 4 58 273 432 340 295
1969-71 7 73 201 389 333 273
1972-74 8 88 165 335 363 276
1975-77 10 107 170 293 373 274
1978-80 12 135 196 230 345 267
Table Ilb Registrations of invasive cancer of the
cervix in Scotland
Rates per million women
Age group
Year 15-24 25-34 35-44 45-54 55-64 65+
1960-62 1 61 243 399 339 279
1963-65 2 53 267 389 328 281
1966-68 0 79 254 471 377 291
1969-71 7 60 172 364 349 264
1972-74 5 103 173 326 350 258
1975-77 7 92 168 287 378 264
1978-80 19 145 189 209 351 252
These changes in registration rates shown in
Tables IIa and Ilb correspond to the patterns of
mortality described earlier.
Since registration data are available for shorter
periods than mortality data it is not possible to
carry out such a detailed cohort analysis as for the
mortality data. However some information is
available for cohorts of women born between
about 1901 and 1951. The rates are plotted in
Figures 4 and 5. The general pattern for both
countries is similar to that for the mortality rates;
there is a marked increase in rates for successive
cohorts of women born in years around 1931, 1941
and 1951.
Registration ratesfor carcinoma in situ
Carcinoma in situ registration rates, based on the
same sources as those for invasive cancer, are given
in Tables Illa and lIlb. The data given in these
tables are subject to a number of caveats. First, and
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In England and Wales there was a considerable
increase in registrations at ages below 35 years
during the years 1963-80, the rate having increased
4-fold at ages 15-24 (though there are still fewer
than 50 cases a year in this age group) and by a
factor of 21 at ages 25-34. Some of this increase
may be ascribed to early diagnosis of microinvasive
and some invasive cases discovered as a direct
result of screening; thus to some extent the rates
depend on the level of screening and they are not in
fact true incidence rates. However, while this could
be the complete explanation of the increase in the
early years of the screening programme it seems
unlikely to be so in more recent years. At ages 35-
44 there have been substantial decreases in the
rates, though that for ages 35-39 started to increase
in 1975 and that for ages 40-44 four years later. At
ages 45-54 an initial rise has been followed by a
fall to about half of the peak rate.
In Scotland the pattern of change is very similar
to that for England and Wales. However there is
considerable year to year fluctuation in rates
because of the small numbers involved.
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Figure 4 Cohort registration rates for carcinoma of
the cervix in England and Wales 1962-1980. Rates are
plotted for women registered at specified ages and
born in groups of years centred on January 1st 1901,
1911 etc. Most points are based on registration data
for 5 years. The first point for all cohorts except 1951
is based on 4 years' data.
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Figure 5 Cohort registration rates for carcinoma of
the cervix in Scotland 1961-1980. Rates are plotted for
women registered at specified ages and born in groups
of years centred on January 1st 1901, 1911 etc. Each
point is based on registration data for 5 years.
most obviously, the rates are to a considerable
extent a reflection of the numbers of smears taken:
in general as the number of smears taken increases
the number of 'positive' cases will increase and,
since registrations are expressed as rates relative to
the total population rather than to the numbers
who have been screened, this will appear as an
increase in rates. Secondly, it seems fairly certain
that not all cases of carcinoma in situ are in fact
notified to cancer registries. However it is possible
to draw one, admittedly tentative, conclusion from
Table Illa. In England and Wales, between 1972-74
and 1978-80, the number of smears notified to the
D.H.S.S. increased by only about 19% - from
about 2.31 million to about 2.75 million per year. It
is estimated that in 1978-80 more than 60% were
examinations for women who had had previous
smears (unpublished data provided by D.H.S.S.). In
general it is to be expected that the 'positive' rate
will decrease with repeated screenings since an
initially existing pool of positive cases (sometimes
called the 'prevalence cases') will be depleted
Table Illa Registrations of carcinoma in situ of
the cervix in England and Wales
Rates per million women
Age group
Year 15-24 25-34 35-44 45-54 55-64 65+
1963-65 6 62 121 69 20 11
1966-68 26 218 363 215 45 14
1969-71 36 254 270 172 44 12
1972-74 58 316 271 148 49 14
1975-77 82 492 355 148 51 17
1978-80 90 616 420 151 55 15
Table IlIb Registrations of carcinoma in situ of
the cervix in Scotland
Rates per million women
Age group
Year 15-24 25-34 35-44 45-54 55-64 65+
1960-62 1 79 126 79 24 18
1963-65 7 133 218 137 40 17
1966-68 28 316 494 309 60 17
1969-71 37 307 320 182 62 14
1972-74 50 374 244 137 40 14
1975-77 73 481 314 113 41 14
1978-80 94 568 392 102 39 10
leaving only false negatives and new (incident) cases
to be detected at later screenings. Thus it might be
expected that the registration rate for carcinoma in
situ would have decreased between 1972-74 and
1978-80 since the increase in the number of smears
taken was relatively small and in the earlier period
a greater propoertion would have been 'first time'
smears. Table Illa shows that in fact at ages 15, 24,
25-34 and 35-44 the rates between 1972-74 and
1978-80 increased substantially particularly among
women aged 25-34. This strongly suggests that
there has been a true increase in premalignant lesions in recent years. There are alternative
explanations: for instance it might be that a greater
proportion of high-risk women have come forward
for screening in recent years, and that the rates are
therefore biased, or that the interval between
smears has increased so that there is a greater chance of new lesions arising. We know of no
evidence in favour of either of these possibilities and it seems improbable that these factors would
affect only younger women and that the rates
would have continued to increase. Table ITlb shows
similar changes for rates of carcinoma in situ in
Scotland.
The high rates shown in Tables Illa and ITlb for the period 1966-68, particularly for age-groups 35-
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44 and 45-54, suggest that large numbers of
'prevalence cases' were picked up in the early
stages of the screening programme.
Relationship between numbers of cervical smears and
registrations ofcarcinoma in situ
In Tables IVa and IVb we present the numbers of
registrations of carcinoma in situ related to
estimated numbers of smears taken in each year for
various age groups. The numbers of registrations
used for these tables are taken from published
cancer registration data as explained above. The
estimated numbers of smears for England and
Wales are based on the summary forms SBH140
submitted to the D.H.S.S. by Area Health
Authorities and cervical smear forms sent to the
National Health Service Central Register (Roberts,
1982); similar arrangements exist for the Scottish
data. Table IVa shows that in England and Wales
rates of carcinoma in situ per thousand smears
taken have been increasing, the sharpest increase
occurring among women aged 25-29 and 30-34. In
these two age groups the total number of smears
Table IVa Registrations of carcinoma in situ of the
cervix in England and Wales
Rates per 1000 smears
Age group
Year Less than 25 years 25-29 30-34 35 and over
1973 0.37 1.06 1.61 1.33
1974 0.40 1.31 1.77 1.39
1975 0.42 1.50 1.82 1.48
1976 0.52 1.72 2.10 1.48
1977 0.50 1.94 2.61 1.63
1978 0.53 2.05 2.64 1.43
1979 0.47 2.08 2.96 1.46
1980 0.53 2.20 3.18 1.49
Table lVb Registrations of carcinoma in situ
of the cervix in Scotland
Rates per 1000 smears
Age group
Year Less than 30 years 30-34 35 and over
1973 0.87 1.59 1.27
1974 0.74 1.80 1.45
1975 0.99 0.93 1.33
1976 1.42 2.00 1.62
1977 1.16 2.73 1.35
1978 1.02 1.93 1.46
1979 1.18 2.25 1.29
1980 1.73 2.44 1.63
increased by only 11% between 1973 and 1980
whereas the number of cases of carcinoma in situ
registered increased by 131%. This again provides
evidence that there is a real increase in incidence
particularly among younger women. The pattern in
Table IVa is similar to that reported by Roberts
who showed an increasing rate of 'positive' cases
(smears classified cytologically as 'severe
dysplasia/carcinoma in situ' or 'carcinoma in situ/?
invasive') during the period, this increase again
being most marked in age groups 25-29 and 30-34.
Of the cytologically positive cases for which
a histological diagnosis is available about 50%
are classified as carcinoma in situ; this figure
changed little during the period covered by Table
IVa. (The estimated numbers of cases of carcinoma
in situ in the paper by Roberts are substantially
greater than the numbers of registrations used in
Tables Illa and IVa of the present paper. This
difference may be due to the fact that not all cases
are notified to cancer registries. However, the
discrepancy may also be due to the methods used
in estimating the numbers of cases for Roberts'
paper; these estimates are based on statistical
returns made to the D.H.S.S., and it is possible that
some biopsy findings corresponding to positive
smears are counted twice because the smear was
repeated; we have no indication of the magnitude
of this possible source oferror.)
For Scotland we have estimated from
unpublished data the annual numbers of smears in
each age-group; Table lVb shows that rates of
registered cases of carcinoma in situ per thousand
smears have increased also in Scotland between
1973 and 1980 for all ages. As in England and
Wales the largest increases have occurred in women
aged less than 35 years, in which age group the
total number of smears increased by 18% during
this period whereas the number of cases of
carcinoma in situ increased by 112%.
Discussion
The effects ofthe screening programme
The evidence from mortality rates presented above
has been commented on by several previous
authors (e.g. Beral, 1974; Yule, 1978; Draper &
Cook, 1983). Data showing an increasing rate of
positive smears as observed in either family
planning clinics or district cytology laboratories
have been presented by Bamford et al. (1982),
Wolfendale et al. (1983) and Mackenzie et al.
(1983).
In our view the only reasonable interpretation of
the available data is that there has been among
younger women a very substantial increase in the374 G.A. COOK & G.J. DRAPER
rates of carcinoma in situ. This is evident from the
data presented in Tables Illa, IlIb, IVa and IVb. In
view of the known epidemiological features of
cervical neoplasia, and the probably increasing
exposure to a sexually transmissible agent resulting
from changing patterns of sexual behaviour, this
increase was predictable. The increasing use of non-
barrier methods of contraception (Wright et al.,
1978), the possible direct effects of the
contraceptive pill (Vessey et al., 1983) and changes
in smoking habits may have contributed to the
increase, though the effects of these factors are in
varying degrees hard to quantify and controversial.
It is not clear to what extent the substantial
decreases in the rates for mortality and registrations
of invasive cancer of the cervix at ages 35-44 and
45-54 can be attributed to screening, since
improvements occurred at different times for
different age groups. These reductions might at
least partly be explained by differences in exposure
to risk for different cohorts.
The reductions could conceivably also be partly
explained by the increasing prevalence of
hysterectomy performed for reasons other than
cervical cancer. The effect of such an increase is
effectively to decrease the population at risk, since
the appropriate denominator for cervical cancer
rates is the number of cervices rather than the
number of women. The proportion of women
having had a hysterectomy by any given age can be
estimated using data from the Hospital Inpatient
Enquiry (HIPE), which is based on hospital
discharges in England and Wales, as described by
Alderson & Donnan (1978). Their calculations have
been extended by Parkin et al. (submitted for
publication) and by the present authors to provide
estimates of the percentages of women in each 5-
year age-group who had ever had a hysterectomy,
for years between 1963 and 1983. There is a
pronounced cohort effect in these rates, and at ages
between 35 and 69 the rates for 1983 are two or
three times as large as those for 1963. The
maximum value calculated is for age group 55-59
in 1983, for which it is estimated that the
prevalence of hysterectomy is about 14%. However,
as Alderson and Donnan pointed out in looking at
mortality rates up to 1975, the effect of the
adjustment for hysterectomy rates is relatively
small. Thus changing hysterectomy rates cannot
explain the trends described in the present paper.
If the screening programme has in fact resulted in
a reduction in mortality this should be evident in
the rates by about the mid-1970s: it would be
expected that within any cohort, and using
unscreened cohorts as a comparison, the rates for
age-groups covered by the screening programme
would be lower than would be predicted from their
rates at ages pre-dating the screening programme.
An examination of Figures 2 and 3, and of the
more detailed tables on which they are based,
provides some limited support for the suggestion
that after making allowance for the low rates in
some cohorts there is indeed the predicted effect of
screening at times subsequent to the
implementation of a widespread screening
programme.
Macgregor & Teper (1978) showed that the
mortality rates from cervical cancer for women
aged 55-64 in those regions of Scotland where
more comprehensive screening programmes were
introduced declined sharply during the period 1968-
76 compared with the rest of Scotland. There
appears to be little difference between the various
regions in mortality rates for those aged 35-54: all
rates have declined. However for those aged 25-34
Macgregor and Teper showed that a small decrease
in mortality rates in Scotland became a small
increase when the two "well screened" regions were
excluded. It should be emphasised that the numbers
of cases on which some of their analyses are based
are very small.
Parkin et al. (submitted for publication) have
attempted to estimate the number of cases of
invasive cancer of the cervix which would have
been registered during one year, 1978, had there
been no screening programme in England and
Wales. By making various assumptions about the
natural history of cervical neoplasia and taking hysterectomy rates into account they have
calculated that the level of screening during the
fifteen years before that date had prevented up to
25% of the potential cases of invasive disease.
Although this is a substantial number it could have
been greater if the resources devoted to screening
had been more efficiently used since it is well
known that the acceptance of screening in England
and Wales has been greater among younger women
and those of higher social class, and that those at
higher risk have not been properly covered by the
screening programme.
We conclude that, although the effectiveness of
the screening programme in Great Britain has never
been evaluated, it appears likely that it has in fact
had some impact in reducing mortality and has
probably limited the rise among younger women.
Future screeningpolicy
It is difficult to interpret the patterns of rates
presented in this paper and to make predictions
about future rates. If, as seems likely, the present increase among younger women continues through their lifespan, and if succeeding cohorts show the
same and perhaps even a greater increase, the age distributions of both carcinoma in situ and invasive
cancer during successive calendar years may showCERVICAL CANCER AND CARCINOMA IN SITU 375
considerable changes. Recent policy guidelines for
England and Wales, as described by Draper (1982)
and Burslem (1983), explicitly acknowledge that the
incidence among younger women may be
increasing. However it should be emphasised that
the level of screening among younger women
should not be unreasonably increased at the
expense of neglecting older women. In particular we
would emphasise yet again that it is important that
any woman over 35 who has not been screened
should have at least one smear.
There are still doubts about the most effective
strategy for screening and, particularly in view of
current trends in incidence, very careful monitoring
of the screening effort and the rates of both pre-
clinical and clinical disease will be required. A
prerequisite for such monitoring is the development
of well-designed computerised information systems
which will make it possible to record and analyse
the necessary data.
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